Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
0(0%)
Results Posted
14%(1 trials)
Terminated
2(20%)

Phase Distribution

Ph phase_1
7
70%
Ph not_applicable
2
20%

Phase Distribution

7

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
7(77.8%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
77.8%
Most Advanced
Phase 1

Trials by Phase

Phase 17 (77.8%)
N/A2 (22.2%)

Trials by Status

completed770%
terminated220%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10